• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Loss of tight junction protein promotes development of precancerous cells

Bioengineer by Bioengineer
December 16, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer. Understanding how claudin 18 loss occurs and what pathways it regulates may provide new strategies to inhibit neoplastic progression in human gastric cancer patients.

In a first-of-its-kind investigation, researchers at Beth Israel Deaconess Medical Center analyzed gastric tissues from mice infected with the bacterium H pylori – which can cause stomach ulcers, gastritis and gastric cancer – as well as from mice genetically engineered to lack claudin 18. The team demonstrated that mice infected with the bacteria lost claudin 18 overtime compared to uninfected mice. The team further showed that the lack of claudin 18 alone was enough to prompt the development of precancerous, abnormal cells and polyps in the engineered mouse model. Their findings were published in the journal Gastroenterology.

“The results were very surprising,” said lead author Susan J. Hagen, PhD, an investigator at BIDMC and an Associate Professor of Surgery at Harvard Medical School. “Epithelial cells express numerous varieties of claudin proteins at the tight junction. We thought that other claudin molecules would compensate for the loss of claudin 18. It is incredible that manipulating only one protein in the stomach results in gastric cancer development.”

###

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, MetroWest Medical Center, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.

Media Contact
Jacqueline Mitchell
[email protected]
617-667-7306
https://www.bidmc.org/about-bidmc/news/2018/12/loss-of-tight-junction-protein-promotes-development-of-precancerous-cells

Tags: cancerMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Mayo Clinic Researchers Discover “Sugar Coating” Technique to Shield Cells from Type 1 Diabetes Damage

August 1, 2025
blank

Mayo Clinic Researchers Discover “Sugar Coating” Technique to Shield Cells Targeted in Type 1 Diabetes

August 1, 2025

Moffitt Cancer Center Initiates Study to Enhance Advanced Lung Cancer Outcomes in Black Patients

August 1, 2025

Breakthrough in Melanoma Guidance System Offers New Hope to Halt Metastasis

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    38 shares
    Share 15 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.